A Study to Evaluate the Efficacy and Safety of AD-221 and AD-221A

NCT05131997 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

290

Enrollment

INDUSTRY

Sponsor class

Conditions

Primary Hypercholesterolemia

Interventions

DRUG: AD-221
DRUG: AD-221A
DRUG: AD-221B
DRUG: AD-221C

Sponsor

Addpharma Inc.